NIKA PHARMACEUTICALS, INC
PublicBiotech · Henderson, NV
NIKA PHARMACEUTICALS holds exclusive rights to produce and distribute a thymus-derived HIV drug candidate (TNG), several dietary supplements such as Carotilen and Physiolong, and Inactivated Pepsin Fraction-based medicines. It also holds an 80% stake in Nika Europe, which is planning a pharmaceutical factory.
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
No rounds recorded yet
This company has no fundraising rounds in the database.
SEC filings
View all 27 filings on EDGAR- Form 10-QAug 10, 20260001826466-26-000049EDGAR
- Form 10-QMay 12, 20260001826466-26-000039EDGAR
- Form 10-KMar 25, 20260001826466-26-000026EDGAR
- Form 10-QNov 7, 20250001826466-25-000096EDGAR
- Form 10-QAug 14, 20250001826466-25-000087EDGAR
- Form 10-QMay 13, 20250001826466-25-000058EDGAR
- Form 10-KMar 31, 20250001826466-25-000030EDGAR
- Form 10-QNov 12, 20240001826466-24-000146EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.